Applying Lucentis for the treatment of retinopathy of prematurity

Purpose: to evaluate the efficacy of Lucentis for the treatment of retinopathy of prematurity (ROP). Material and methods. 51 infants (102 eyes) with the gestational age between 24 and 33 weeks were given intravitreal injections of Lucentis, All patients selected had ROP stages I+, II+, III or III+...

Full description

Bibliographic Details
Main Authors: S. V. Lesovoy, O. A. Boginskaya
Format: Article
Language:Russian
Published: Real Time Ltd 2022-12-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1096